Should hematopoietic growth factors routinely be given concurrently with cytotoxic chemotherapy?

Clin Pharmacol Ther. 1996 Jan;59(1):1-6. doi: 10.1016/S0009-9236(96)90016-8.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Clinical Trials as Topic
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Neutropenia / chemically induced
  • Neutropenia / prevention & control*
  • Opportunistic Infections / etiology
  • Opportunistic Infections / prevention & control*
  • Recombinant Proteins / therapeutic use

Substances

  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • Granulocyte-Macrophage Colony-Stimulating Factor